Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2023 ∙ Law, M. Ho, S. S. H. Tsang, G. K. C. Ho, C. M. Y. Kwan, C. M. Yan, V. K. C. Yiu, H. H. E. Lai, F. T. T. Wong, I. C. K. Chan, E. W. Y.
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Kuniduzi, Y. Chen, B. Zeng, J. Sun, X. Chen, T. Qian, X. Wang, J. Liang, F. Abuduxukuer, R. Yusufu, M. Xu, S. Zhang, X.
Efficacy and safety of a fourth dose of the COVID-19 vaccine in kidney transplant recipients: A systematic review and meta-analysis
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Taheri, S.
Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Joudeh, A. I. Lutf, A. Q. Mahdi, S. Tran, G.
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Conti, A. Broglia, G. Sacchi, C. Risi, F. Barone-Adesi, F. Panella, M.
Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis
Children Adolescents Adults Meningococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Ma, J. Chen, L. Tang, S. Shi, Y.
Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials
Pregnant women RSV (Respiratory syncytial virus) Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Zeevaert, R. Thiry, N. Maertens de Noordhout, C. Roberfroid, D.
Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis
Adults Older adults Herpes zoster Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Ibrahim Khalil, Ahmadaye Zhang, Li Muwonge, Richard Sauvaget, Catherine Basu, Partha
Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials
All age groups Human papillomavirus (HPV) Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Wen, J. Liu, Q. Tang, D. He, J. Q.
Efficacy of BCG Vaccination against COVID-19: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Dou, D. Zhang, F. Deng, X. Ma, Y. Wang, S. Ji, X. Zhu, X. Wang, D. Zhang, S. Zhao, L.
Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving anti-TNF therapy: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...